1217683-44-7 Usage
Description
(R)-3-METHOXYCARBONYLMETHYL-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is a chemical compound with the formula C13H23N3O4. It is a derivative of piperazine, a heterocyclic compound commonly used in pharmaceuticals and agrochemicals. (R)-3-METHOXYCARBONYLMETHYL-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is a ter-butyl ester, meaning it contains a tertiary butyl group in its structure, which makes it more stable and less reactive than other esters. It is of interest in pharmaceutical research and development due to its potential as a building block for the synthesis of bioactive molecules.
Uses
Used in Pharmaceutical Research and Development:
(R)-3-METHOXYCARBONYLMETHYL-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER is used as a building block for the synthesis of bioactive molecules in the pharmaceutical industry. Its specific properties and potential uses would require further study and characterization to fully understand its capabilities and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1217683-44-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,7,6,8 and 3 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1217683-44:
(9*1)+(8*2)+(7*1)+(6*7)+(5*6)+(4*8)+(3*3)+(2*4)+(1*4)=157
157 % 10 = 7
So 1217683-44-7 is a valid CAS Registry Number.
1217683-44-7Relevant articles and documents
TASPASE1 INHIBITORS AND USES THEREOF
-
Paragraph 0483-0484; 0525; 0526, (2021/05/29)
Disclosed herein, inter alia, are compounds and methods for inhibiting Taspasel and the treatment of cancer.
Benzodiazepine and Pyridodiazepine Derivatives
-
, (2011/12/12)
The present application relates to benzodiazepine and pyridodiazepine derivatives of formula (I) wherein R1, R2, R3, R4, X1, Y1, Y2, and Y3 are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.
QUINOLINE DERIVATIVES AS ANTIBACTERIALS
-
Page 15, (2010/02/06)
The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt and/or N-oxide thereof: corresponding novel medicaments, pharmaceutical compositions and/or methods of
